Literature DB >> 6425002

The serum sensitivity, colonial morphology, serogroup specificity, and outer membrane protein of Pseudomonas aeruginosa strains isolated from several clinical sites.

N L Schiller, R A Hatch.   

Abstract

Ninety-three strains of Pseudomonas aeruginosa, isolated from 68 patients hospitalized with respiratory tract infections, burns, urinary tract infections, and other illnesses, were examined for: 1) sensitivity to the bactericidal activity of fresh normal human serum (FHS); 2) colonial morphology; 3) serogroup designation; and 4) outer membrane protein (OMP) profile. The purpose of this study was to determine if there was any relationship between any of these microbial characteristics and the propensity of this microorganism to infect a specific clinical site or tissue. The results of this study can be summarized as follows: 1) slime-producing strains were generally more serum-sensitive than non-slime producers, although serum sensitivity was not related to slime production per se; 2) CF strains were much more serum-sensitive than non-CF strains; 3) the clinical isolation site appeared to be the predominant determinant of a strain's sensitivity to FHS; 4) the ability of P. aeruginosa to colonize/infect a specific clinical site or resist the bactericidal activity of FHS was generally unrelated to serogroup specificity; and 5) whereas the OMP profile of a particular strain does not appear to correlate with its response to the bactericidal effect of FHS, it does appear to be related to its clinical isolation site.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6425002     DOI: 10.1016/0732-8893(83)90044-5

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  14 in total

1.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa.

Authors:  R A Hatch; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

4.  Isolation and characterization of two genes, waaC (rfaC) and waaF (rfaF), involved in Pseudomonas aeruginosa serotype O5 inner-core biosynthesis.

Authors:  T R de Kievit; J S Lam
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

5.  Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.

Authors:  T I Nicas; D W Frank; P Stenzel; J D Lile; B H Iglewski
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

6.  Characterization of the extended-spectrum β-lactamases and determination of the virulence factors of uropathogenic Escherichia coli strains isolated from children.

Authors:  Branka Bedenić; Jasmina Vraneš; Sabine Hofmann-Thiel; Marija Tonkić; Anita Novak; Viljemka Bučević-Popovic; Harald Hoffmann
Journal:  Wien Klin Wochenschr       Date:  2012-08-16       Impact factor: 1.704

7.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

Review 8.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 9.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

10.  Prevalence of gca, a gene involved in synthesis of A-band common antigen polysaccharide in Pseudomonas aeruginosa.

Authors:  H L Currie; J Lightfoot; J S Lam
Journal:  Clin Diagn Lab Immunol       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.